Delivery Order SPE2DB20D1100-SPE2DB25FB9F1
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,801.80 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens on August 7, 2025. This non-set-aside, competitively awarded contract represents a firm fixed-price delivery order with an ultimate completion date of August 8, 2025. The product will be delivered to the company's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters as a major pharmaceutical...
- The Defense Logistics Agency awarded a $17,635.09 delivery order to AmerisourceBergen Drug Corp for Trulicity 3 mg/0.5 ml pens on December 12, 2025, with a completion date of December 15, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The pharmaceutical product will be delivered to AmerisourceBergen's Conshohocken, Pennsylvania facility, which serves as the company's corporate headquarters and primary distribution center for federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $3,966.30 to AmerisourceBergen Drug Corp for the supply of Trulicity 3 mg/0.5 mL pens on December 22, 2025. This competitively awarded, firm fixed-price contract represents a non-set-aside delivery order with an ultimate completion date of December 23, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,085.37 to AmerisourceBergen Drug Corp for the supply of Trulicity 4.5 mg/0.5 mL pens on September 26, 2025, with completion targeted for September 29, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to support federal pharmaceutical procurement needs. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, which serves as the company's...
- The Defense Logistics Agency awarded a delivery order valued at $3,283.98 to AmerisourceBergen Drug Corp for the supply of Trulicity 0.75 mg/0.5 mL pens. This competitive award, issued on August 12, 2025, with an ultimate completion date of August 13, 2025, represents a firm fixed price delivery order with no set-aside designation. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. AmerisourceBergen Drug...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for $1,453.70 on November 18, 2025, for the supply of Trulicity 4.5 mg/0.5 mL pens with an ultimate completion date of November 19, 2025. This is a firm fixed price delivery order with no set-aside designation, issued under competitive procedures. The product will be delivered to the company's facility in Conshohocken, Pennsylvania, AmerisourceBergen's headquarters location. This delivery order is a...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $3,669.96 by the Defense Logistics Agency on July 28, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pens. The contract utilizes firm fixed pricing with no set-aside designation and is scheduled for completion by July 29, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,351.35 to AmerisourceBergen Drug Corp for the supply of Trulicity 3 mg/0.5 ml pen injections on June 4, 2025, with an ultimate completion date of June 5, 2025. This is a firm fixed price delivery order with no set-aside designation, awarded competitively to AmerisourceBergen's Corporate Office division located in Conshohocken, Pennsylvania. The contract represents a single transaction for pharmaceutical supply under the...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,788.24 for Trulicity 1.5 mg/0.5 ml pens on October 17, 2025, with completion targeted for October 20, 2025. This competitively awarded, firm fixed-price delivery order represents a small-value pharmaceutical procurement executed through AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The contract specifies performance at AmerisourceBergen's Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $6,211.15 to AmerisourceBergen Drug Corp for Trulicity 3 mg/0.5 ml pens on December 16, 2025, with an ultimate completion date of December 17, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to support federal medical procurement needs. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FB9F1Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $6,631.17 to AmerisourceBergen Drug Corp for the supply of Trulicity 3 mg/0.5 ml pens on April 24, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is classified as a delivery order with an ultimate completion date of April 25, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary operations. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen serves as a critical vendor for federal medical procurement, supplying a comprehensive portfolio of brand-name and generic medications, vaccines, and medical devices to support military healthcare systems and the Defense Health Agency. The company's extensive contract history with the DLA demonstrates its capability to fulfill diverse pharmaceutical requirements through competitive procurement processes.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.6k | 4/24/25 |